Home / Inspections / 1006746

FDA Inspection 1006746 — Vericel Corporation

Vericel Corporation — FEI 3002836339

The FDA completed an inspection of Vericel Corporation on May 27, 2016 in Cambridge, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 27, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Cambridge, MA (United States)

Facility

Other inspections at this facility

  • 1249999 (VAI Wed Sep 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1210597 (VAI Fri Jul 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 870615 (VAI Wed Mar 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 747422 (VAI Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 608350 (VAI Fri Aug 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources